MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results

MiMedx Group (MDXG) Reports Q4 Loss of $0.17/sh

March 8, 2021 5:36 PM EST

MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of ($0.17), versus ($0.07) reported last year. Revenue for the quarter came in at $68.55 million, versus $76.4 million reported last year.

Outlook for 2021:

The Company expects adjusted net sales will increase 10% or more in 2021 over the prior year, assuming MiMedx is able to sell its micronized, particulate, and umbilical cord products for the full year. However, the United States Food and Drug Administration ("FDA") may determine that the Company's micronized, particulate, and/or umbilical... More